Patent US5736382A successfully refreshed from Google Patents.
US5736382A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Bacillus cereus strain DGA34
Assignee: Wisconsin Alumni Research Foundation
•
Filing: 1995-06-06
•
Granted: 1998-04-07
•
Expires: 2015-06-06
Abstract
Abstract A novel strain of Bacillus cereus, designated DGA34, has been isolated from the environment. The strain DGA34 is one of a number of B. cereus strains which are useful as biocontrol agents to combat fungal damping off disease in field crop plants, in part because of their production of the antibiotic zwittermicin A. Strain DGA34 has exhibited the best performance among a large number of natural isolates in producing the highest titer of zwittermicin A production.
Inventors
- 👤 Jo Handelsman
- 👤 Lynn M. Jacobson
- 👤 Eric V. Stabb
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-06 17:43
CPC Classifications
C; C12; C12N; C12N1/00; C12N1/20; C12N1/205; C12P; C12P13/00; C12P13/02; C12R; C12R2001/00; C12R2001/01; C12R2001/07
Claims Analysis
Total Claims: 8
Claim 1
Independent Claim
20 words
A biologically pure culture of Bacillus cereus having all of the identifying characteristics of B. cereus strain DGA34, ATCC 55608.
Claim 2
Dependent Claim
20 words
A biologically pure culture of Bacillus cereus having all of the identifying characteristics of B. cereus strain DGA34, ATCC 55608.
Claim 3
Dependent Claim
40 words
A biologically pure culture of a mutant strain obtained from a culture having all of the identifying characteristics of Bacillus cereus strain DGA34, ATCC 55608, the mutant strain having the ability to produce zwittermicin A in excess of 50 μg/ml.
Claim 4
Dependent Claim
40 words
A biologically pure culture of a mutant strain obtained from a culture having all of the identifying characteristics of Bacillus cereus strain DGA34, ATCC 55608, the mutant strain having the ability to produce zwittermicin A in excess of 50 μg/ml.
Claim 5
Dependent Claim
43 words
An inoculum for application to alfalfa comprising a carrier and an effective quantity of bacteria selected from the group consisting of Bacillus cereus DGA34, ATCC 55608, and mutants of Bacillus cereus DGA34, ATCC 55608, which produce zwittermicin A in excess of 50 μg/ml.
Claim 6
Dependent Claim
43 words
An inoculum for application to alfalfa comprising a carrier and an effective quantity of bacteria selected from the group consisting of Bacillus cereus DGA34, ATCC 55608, and mutants of Bacillus cereus DGA34, ATCC 55608, which produce zwittermicin A in excess of 50 μg/ml.
Claim 7
Independent Claim
41 words
A method for producing zwittermicin A comprising culturing in a suitable medium an effective quantity of bacteria selected from the group consisting of Bacillus cereus DGA34, ATCC 55608 and mutants thereof which produce zwittermicin A, and recovering the zwittermicin A produced.
Claim 8
Independent Claim
41 words
A method for producing zwittermicin A comprising culturing in a suitable medium an effective quantity of bacteria selected from the group consisting of Bacillus cereus DGA34, ATCC 55608 and mutants thereof which produce zwittermicin A, and recovering the zwittermicin A produced.
References Cited (Backward Citations)
US4259317A
Cited
US4250170A
Cited
WO1988000966A1
Cited
EP0278959A1
Cited
US4877738A
Cited
US5049379A
Cited
US5543301A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 2001-04-06 | 2001-10-06 | 2002-04-07 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 2005-04-06 | 2005-10-06 | 2006-04-07 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2009-04-06 | 2009-10-06 | 2010-04-07 | $7700.00 | Window Closed / Lapsed |